Last week, the FDA approved the first ever pill specifically intended to treat postpartum depression. Nicole Cirino, MD, reproductive psychiatrist, chief of division of reproductive psychiatry, professor at Baylor College of Medicine, and Postpartum Support International board member, provides an expert look at Zurzuvae, the new medication which could help the estimated 1 in 8 women in the United States experiencing symptoms of depression after giving birth.